Copy Link Print Information

Tifcemalimab

(Synonyms: JS004; Icatolimab)
Revisión del cliente

Based on 1 Customer Validation

Tifcemalimab (JS004; Icatolimab) is a humanized IgG4 monoclonal antibody against BTLA (B and T lymphocyte attenuator). By binding to BTLA, tifcemalimab blocks the interaction of HVEM-BTLA, thereby inhibiting the BTLA-mediated inhibitory signaling pathway. Tifcemalimab can be used in research related to squamous cell non-small cell lung cancer.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza : 96.02%
  • No. CAS: 2236068-83-8
  • Peso molecular:146 kDa
  • Almacenamiento:
    Shipping with dry ice

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Tifcemalimab
  • Experimental Validation Results for Tifcemalimab
  • Tifcemalimab Chemical Structure
    Tifcemalimab Chemical Structure
No. CAS: 2236068-83-8
Tamaño
Precio
Stock
Cantidad
Amount: USD 0.00
Please select quantity
or
or

* Seleccione Cantidad antes de agregar artículos.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Tifcemalimab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Encuentre su distribuidor local Your local distributor: Hycultec GmbHHycultec
  • Actividad biológica
  • Chemical Information
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
Top Publications Citing

Use of MCE Products

Keywords

MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Inicie sesiòn
Registrar
Sign in to MedChemExpress
Registrar una cuenta nueva

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    Human IgG4 kappa

  • 1/16

    Immobilized hu-BTLAECD-his can bind Tifcemalimab. The EC50 for this effect is 16.01 ng/mL.

  • Tifcemalimab Chemical Structure
    1/16
  • Tifcemalimab
  • Immobilized hu-BTLAECD-his can bind Tifcemalimab. The EC50 for this effect is 16.01 ng/mL.